文章名稱引用次數(shù)

• Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: Microbial analysis from a randomized placebo-controlled trial16
• The nature, consequences, and management of neurological disorders in chronic kidney disease15
• Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study11
• Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial7
• Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys (R) vascular access system7
• Predictors of post-hospitalization recovery of renal function among patients with acute kidney injury requiring dialysis6
• The effect of a hemodialysis patient education program on fluid control and dietary compliance6
• Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis6
• Management of pain in end-stage renal disease patients: Short review6
• Effects of acute intradialytic exercise on cardiovascular responses in hemodialysis patients5